Table 1

Characteristics of total patient cohort and of cohort divided into patients with and without type 2 diabetes

Total cohort (n = 1,797)No diabetes (n = 1,294)Diabetes (n = 503)P value
Age (years)69.6 (0.3)69.4 (0.4)70.2 (0.5)0.2
Heart rate (bpm)75.3 (0.4)75.3 (0.5)75.3 (0.8)0.99
Systolic BP (mmHg)122.4 (0.6)121.5 (0.7)125 (1)0.004
RPP (bpm × mmHg)9,152 (73)9,091 (86)9,321 (137)0.16
QRS duration (ms)123 (1)124 (1)122 (1)0.22
Hemoglobin (g/dL)13.4 (0.1)13.6 (0.1)13 (0.1)<0.001
eGFR (mL/min/1.73 m2)57.7 (0.5)59.1 (0.5)54.4 (0.9)<0.001
LVEDD (mm)57.2 (0.2)57.5 (0.3)56.3 (0.4)0.01
LVEF (%)32 (0.2)31.5 (0.3)33.1 (0.4)0.001
Bisoprolol dose (mg/day)3.9 (0.1)3.8 (0.1)4.2 (0.2)0.01
Ramipril dose (mg/day)4.9 (0.1)4.8 (0.1)5.3 (0.2)0.004
Furosemide dose (mg/day)51.2 (1.2)44.6 (1.3)68.3 (2.5)<0.001
Male sex (% [n])73.2 (1,315)72 (932)76.1 (383)0.077
Ischemic etiology (% [n])59.2 (1,064)54.9 (710)70.4 (354)<0.001
ICD in situ (% [n])11.7 (210)11.7 (152)11.5 (58)0.9
CRT in situ (% [n])25.3 (455)25.5 (330)24.9 (125)0.78
NYHA class III/IV (% [n])30.8 (554)28.4 (367)37.2 (187)<0.001
  • Data are presented as mean (SEM) or as indicated. P value compares groups with and without diabetes with unpaired t tests or χ2 tests.

  • BP, blood pressure; LVEDD, left ventricular end-diastolic diameter; RPP, rate-pressure product.